Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

China’s FDA calls for verification data on clinical trials

Late last month the China Food and Drug Administration (CFDA) began mandating that drug registration applicants self-inspect and verify clinical data to ensure that it’s authentic and reliable.

Quintiles announces secondary public offering of about $545m worth of stock

CRO Quintiles on Friday announced the pricing of a secondary public offering of 7,000,000 shares of its common stock at a price to the public of $77.85 per share, which is about $1 more per share than what the stock was selling for on Friday. 

Xcelience invests in CMO Powdersize

CDMO (contract development and manufacturing organization) Xcelience has made a structured cash investment in Pennsylvania-based contract manufacturer Powdersize, which specializes in milling, micronization and powder size classification.  

Charles River renews early-stage partnership with AstraZeneca for five years

Contract research organization Charles River Laboratories has extended its initial three-year strategic partnership with AstraZeneca for an additional five years. 


Parexel to lay off up to 125 transferred GSK employees

Beginning Sept. 30, Massachusetts-based CRO (contract research organization) Parexel will lay off as many as 125 of the 450 employees it brought on from GlaxoSmithKline (GSK) in North Carolina late last year, according to a North Carolina WARN report obtained by

Key Industry Events


Access all events listing

Our events, Shows & Conferences...